Skip to content

Frontlight ResearchEarly access

Institution

Pusan National University

Busan, South KoreaWebsite

Also known as: Busan National University · Miryang National University · 부산대학교 · PNU

1closed trial
73,586publications (OpenAlex)

Closed trials

Completed
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
NCT03929666· Phase 2· Jazz Pharmaceuticals· Source

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Pusan National University
Busan, 49241
1 trial
- NCT03929666A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Conditions

Diseases this institution publishes on or runs trials for.

Institution data: ROR 01an57a31 (CC0-1.0)Updated 14 Nov 2026

Report an error

Pusan National University: trials and research groups – Frontlight Research